These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 15716609)
1. Gene expression analysis of cultured amniotic fluid cell with Down syndrome by DNA microarray. Chung IH; Lee SH; Lee KW; Park SH; Cha KY; Kim NS; Yoo HS; Kim YS; Lee S J Korean Med Sci; 2005 Feb; 20(1):82-7. PubMed ID: 15716609 [TBL] [Abstract][Full Text] [Related]
2. Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome. Lim JH; Kim DJ; Lee DE; Han JY; Chung JH; Ahn HK; Lee SW; Lim DH; Lee YS; Park SY; Ryu HM Placenta; 2015 Mar; 36(3):322-8. PubMed ID: 25595853 [TBL] [Abstract][Full Text] [Related]
3. [Screening and identification of human chromosome 21 genes resulting in abnormal development of fetal cerebral cortex with Down syndrome]. Yu WD; Liang R; Yang LJ; Shang M; Shen H; Guan J; Guo JZ Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2759-63. PubMed ID: 18167266 [TBL] [Abstract][Full Text] [Related]
4. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene. Annerén G; Edman B APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993 [TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling in the adult Down syndrome brain. Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572 [TBL] [Abstract][Full Text] [Related]
6. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome. Greber-Platzer S; Schatzmann-Turhani D; Wollenek G; Lubec G Biochem Biophys Res Commun; 1999 Jan; 254(2):395-9. PubMed ID: 9918849 [TBL] [Abstract][Full Text] [Related]
7. Mental retardation in Down syndrome: from gene dosage imbalance to molecular and cellular mechanisms. Rachidi M; Lopes C Neurosci Res; 2007 Dec; 59(4):349-69. PubMed ID: 17897742 [TBL] [Abstract][Full Text] [Related]
8. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Mao R; Zielke CL; Zielke HR; Pevsner J Genomics; 2003 May; 81(5):457-67. PubMed ID: 12706104 [TBL] [Abstract][Full Text] [Related]
9. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part III). Cheon MS; Kim SH; Ovod V; Kopitar Jerala N; Morgan JI; Hatefi Y; Ijuin T; Takenawa T; Lubec G Amino Acids; 2003; 24(1-2):127-34. PubMed ID: 12624744 [TBL] [Abstract][Full Text] [Related]
10. Screening of human chromosome 21 genes in the dorsolateral prefrontal cortex of individuals with Down syndrome. Kong XD; Liu N; Xu XJ; Zhao ZH; Jiang M Mol Med Rep; 2015 Feb; 11(2):1235-9. PubMed ID: 25370074 [TBL] [Abstract][Full Text] [Related]
11. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part I). Cheon MS; Kim SH; Yaspo ML; Blasi F; Aoki Y; Melen K; Lubec G Amino Acids; 2003; 24(1-2):111-7. PubMed ID: 12624742 [TBL] [Abstract][Full Text] [Related]
12. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome. Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197 [TBL] [Abstract][Full Text] [Related]
13. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II). Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743 [TBL] [Abstract][Full Text] [Related]
14. Decreased AIRE expression and global thymic hypofunction in Down syndrome. Lima FA; Moreira-Filho CA; Ramos PL; Brentani H; Lima Lde A; Arrais M; Bento-de-Souza LC; Bento-de-Souza L; Duarte MI; Coutinho A; Carneiro-Sampaio M J Immunol; 2011 Sep; 187(6):3422-30. PubMed ID: 21856934 [TBL] [Abstract][Full Text] [Related]
15. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells. Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301 [TBL] [Abstract][Full Text] [Related]
16. Expression of trisomic proteins in Down syndrome model systems. Spellman C; Ahmed MM; Dubach D; Gardiner KJ Gene; 2013 Jan; 512(2):219-25. PubMed ID: 23103828 [TBL] [Abstract][Full Text] [Related]
17. Specificity and sensitivity of S100B levels in amniotic fluid for Down syndrome diagnosis. Tort AB; Portela LV; da Purificação Tavares M; Gonçalves CA; Netto C; Giugliani R; Souza DO Life Sci; 2004 Dec; 76(4):379-84. PubMed ID: 15530500 [TBL] [Abstract][Full Text] [Related]
18. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS). Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127 [TBL] [Abstract][Full Text] [Related]
20. Proteomic signatures and aberrations of mouse embryonic stem cells containing a single human chromosome 21 in neuronal differentiation: an in vitro model of Down syndrome. Kadota M; Nishigaki R; Wang CC; Toda T; Shirayoshi Y; Inoue T; Gojobori T; Ikeo K; Rogers MS; Oshimura M Neuroscience; 2004; 129(2):325-35. PubMed ID: 15501590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]